J Korean Med Sci.  2014 Jun;29(Suppl):S40-S46. 10.3346/jkms.2014.29.S.S40.

Compensation for Occupational Cancer

• Kim I
• Kim EA
• Kim JY

• KMID: 1791998
• DOI: http://doi.org/10.3346/jkms.2014.29.S.S40

Abstract

The legal scope and criteria for occupational cancer in Korea was out of date. The aim of this study was to review the current criteria for occupational cancer and amend the existent criteria on the basis of recent scientific evidence. The scientific evidence and the legal list of occupational cancer were analyzed to identify the causes of occupational cancer on a global scale. The relationship between compensated occupational cancer cases and carcinogen exposure in Korea was examined. The factors associated with specific causes and target cancers were determined to produce additional criteria. Five-hundred and nineteen cases of 2,468 were awarded compensation for occupational cancer including lung, malignant mesothelioma, lymphohematopoietic, and liver cancers from January 2000 to October 2012. Between 1996 and 2005, benzene accounted for 84.4% of cases, and between 1999 and 2005, asbestos was associated with 62.3% of cases. Fourteen novel causative agents and 12 additional target cancers were identified and the final guidelines were amended to include 23 causative agents and 21 target cancers. This amendment of the criteria for occupational cancer represents the widest change in Korean history and is expected to improve the understanding of occupational cancer by providing an up-to-date and accurate reference guide.

Keyword

Occupational Cancer; Compensation; Korea

MeSH Terms

Asbestos/toxicity
Benzene/toxicity
Carcinogens/toxicity
Female
Humans
Insurance, Health/*economics
Middle Aged
Neoplasms/chemically induced/*economics
Occupational Diseases/*economics/mortality
Occupational Exposure/*adverse effects
Republic of Korea
Workers' Compensation/*economics/legislation & jurisprudence/standards
Asbestos
Benzene
Carcinogens

Reference

1. Kim HR. Overview of asbestos issues in Korea. J Korean Med Sci. 2009; 24:363–367.

2. Kim I, Kim HJ, Lim SY, Kongyoo J. Leukemia and non-Hodgkin lymphoma in semiconductor industry workers in Korea. Int J Occup Environ Health. 2012; 18:147–153.

3. Lee N, Lee BK, Jeong S, Yi GY, Shin J. Work environments and exposure to hazardous substances in Korean tire manufacturing. Saf Health Work. 2012; 3:130–139.

4. Koh DH, Kim TW, Yoon YH, Shin KS, Yoo SW. Lymphohematopoietic cancer mortality and morbidity of workers in a refinery/petrochemical complex in Korea. Saf Health Work. 2011; 2:26–33.

5. Kim EA. The criteria and compensation of occupational cancer. Mon Labor Rev. 2013; 100:26–39.

6. Ahn YS. Occupational cancer update. Korean J Occup Environ Med. 2011; 23:235–252.

7. Kim EA. The topic in the late 1990's, work-relatedness of occupational cancer. Ind Health. 2010; 12. 8–14.

8. Ministry of Employment and Labor. Presidential Decree No.22101. The enforcement decree under Industrial Accident Compensation Insurance (IACI) Act . 2010. 03. 26. Partial Amendment.

9. Ministry of Employment and Labor. Act No.8961. Act on The Prevention of Pneumoconiosis and Protection, Etc., of Pneumoconiosis Workers. 2008. 03. 21. Partial Amendment.

10. Kim EA, Kang SK. Historical review of the list of occupational diseases recommended by the International Labour Organization. Ann Occup Environ Med. 2013; 25:14.

11. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide). Lyon, France: IARC;2008. Vol 97.

12. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Painting, Firefighting, and Shiftwork. Vol 98. Lyon, France: 2010.

13. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Some Aromatic Amines, Organic Dyes, and Related Exposures. Lyon, France: IARC;2010. Vol 99.

14. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Pharmaceuticals. Lyon, France: IARC;2012. Vol 100A.

15. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Biological Agents. Lyon, France: IARC;2012. Vol 100B.

16. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Arsenic, Metals, Fibres, and Dusts. Lyon, France: IARC;2012. Vol 100C.

17. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Radiation. Lyon, France: IARC;2012. Vol 100D.

18. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogen Risks to Human; Chemical Agents and Related Occupations. Lyon, France: IARC;2012. Vol 100F.

19. International Labor Office. List of Occupational Diseases (Revised 2010) Identification and Recognition of Occupational Disease: Criteria for Incorporating Diseases in the ILO List of Occupational Disease. Geneva, Swiss: International Labour Organization;2010.

20. Kim EA. Type, Criteria, and Contents List of the Occupational Diseases of Some ILO member state. Incheon, Korea: Occupational Safety and Health Research Institute, Korean Occupational Safety and Health Agency;2012.

21. Park MI, Choi JS, Choi HM, Jang TI, Moon IH, Kim JH, Jang TW, Lee DH, Jung MH, Kang SK. A case of diffuse malignant pleural mesothelioma with occupational asbestos exposure. Korean J Med. 1995; 48:526–530.

22. Kang SK, Ahn YS, Chung HK. Occupational cancer in Korea in the 1990s. Korean J Occup Environ Med. 2001; 13:351–359.

23. Lee WC, Kim DI, Kwon YJ, Kim HR, Kim IA, Ryoo JH, Kim SG. Workers' compensation claims and approval status for occupational cancers in Korea from 2000 to 2009. Korean J Occup Environ Med. 2011; 23:112–121.

24. Cho SH. Guidelines for work-related diseases. J Korean Med Assoc. 2004; 47:65–74.

25. Lim JW, Park SY, Choi BS. Characteristics of occupational lung cancer from 1999 to 2005. Korean J Occup Environ Med. 2010; 22:230–239.

26. Ahn YS. Occupational malignant lymphohematopoietic diseases compensated under the industrial accident compensation insurance from 1996 to 2005. Korean J Occup Environ Med. 2007; 19:81–92.

27. Ahn YS. Characteristics of occupational lung cancers compensated. In : Proceedings of 43th conference of the Korean Society of Occupational and Environmental Medicine; Jeju, Korea. 2009.

28. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S, Rousseau MC, Boffetta P. Listing occupational carcinogens. Environ Health Perspect. 2004; 112:1447–1459.

29. Cheung YH. Cost of illness and health-friendly fiscal policy. Health Welf Policy Forum. 2009; 156:50–61.